Standard BioTools Inc. (LAB)

USD 1.99

(-10.18%)

Inventory Summary of Standard BioTools Inc.

  • Standard BioTools Inc.'s latest annual inventory in 2023 was 20.53 Million USD , down -4.38% from previous year.
  • Standard BioTools Inc.'s latest quarterly inventory in 2024 Q2 was 42.61 Million USD , up 5.6% from previous quarter.
  • Standard BioTools Inc. reported annual inventory of 21.47 Million USD in 2022, up 3.11% from previous year.
  • Standard BioTools Inc. reported annual inventory of 20.82 Million USD in 2021, up 5.77% from previous year.
  • Standard BioTools Inc. reported quarterly inventory of 42.64 Million USD for 2024 Q3, up 0.06% from previous quarter.
  • Standard BioTools Inc. reported quarterly inventory of 40.35 Million USD for 2024 Q1, up 96.56% from previous quarter.

Annual Inventory Chart of Standard BioTools Inc. (2023 - 2001)

Historical Annual Inventory of Standard BioTools Inc. (2023 - 2001)

Year Inventory Inventory Growth
2023 20.53 Million USD -4.38%
2022 21.47 Million USD 3.11%
2021 20.82 Million USD 5.77%
2020 19.68 Million USD 41.81%
2019 13.88 Million USD 6.78%
2018 13 Million USD -13.82%
2017 15.08 Million USD -24.99%
2016 20.11 Million USD 12.22%
2015 17.92 Million USD 12.09%
2014 15.99 Million USD 96.26%
2013 8.14 Million USD 13.66%
2012 7.16 Million USD 20.08%
2011 5.97 Million USD 22.01%
2010 4.89 Million USD 24.03%
2009 3.94 Million USD -27.69%
2008 5.45 Million USD -0.76%
2007 5.49 Million USD 80.97%
2006 3.03 Million USD 0.0%
2001 - USD 0.0%

Peer Inventory Comparison of Standard BioTools Inc.

Name Inventory Inventory Difference
Bionano Genomics, Inc. 22.89 Million USD 10.309%
Prenetics Global Limited 3.12 Million USD -556.683%
Star Equity Holdings, Inc. 3.42 Million USD -500.38%
CareDx, Inc 19.47 Million USD -5.454%
Exact Sciences Corporation 127.47 Million USD 83.893%
Exagen Inc. 2.87 Million USD -615.186%
Inotiv, Inc. 56.1 Million USD 63.401%
Guardant Health, Inc. 61.94 Million USD 66.854%
Biodesix, Inc. 1.4 Million USD -1366.643%
BioNexus Gene Lab Corp. 1.13 Million USD -1704.671%
Precipio, Inc. 384 Thousand USD -5247.135%
iSpecimen Inc. - USD -Infinity%
Natera, Inc. 40.75 Million USD 49.623%
Aspira Women's Health Inc. 227 Thousand USD -8945.374%
23andMe Holding Co. 12.46 Million USD -64.725%
Castle Biosciences, Inc. 7.94 Million USD -158.537%
Personalis, Inc. 5.66 Million USD -262.71%
Aclaris Therapeutics, Inc. - USD -Infinity%
Applied DNA Sciences, Inc. 330.02 Thousand USD -6121.612%
OpGen, Inc. 1.00 USD -2053299900.0%
T2 Biosystems, Inc. 4.81 Million USD -326.084%
Myriad Genetics, Inc. 20.1 Million USD -2.154%
ICON Public Limited Company 1.00 USD -2053299900.0%
NeoGenomics, Inc. 24.15 Million USD 14.998%
Star Equity Holdings, Inc. 3.42 Million USD -500.38%
IDEXX Laboratories, Inc. 380.28 Million USD 94.601%
RadNet, Inc. 1.00 USD -2053299900.0%
MDxHealth SA 2.77 Million USD -638.863%
Psychemedics Corporation 1.00 USD -2053299900.0%
Illumina, Inc. 587 Million USD 96.502%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 32.06 Million USD 35.96%
DarioHealth Corp. 5.06 Million USD -305.63%
Fulgent Genetics, Inc. 5.82 Million USD -252.377%
Sera Prognostics, Inc. - USD -Infinity%
ENDRA Life Sciences Inc. 2.62 Million USD -682.846%
OPKO Health, Inc. 65.69 Million USD 68.746%
Medpace Holdings, Inc. 1.00 USD -2053299900.0%
Neogen Corporation 189.26 Million USD 89.151%
Intelligent Bio Solutions Inc. 777.53 Thousand USD -2540.775%
Prenetics Global Limited 3.12 Million USD -556.683%
Mainz Biomed B.V. 613.63 Thousand USD -3246.11%
bioAffinity Technologies, Inc. 18.48 Thousand USD -110985.263%
Trinity Biotech plc 19.93 Million USD -3.01%
Neuronetics, Inc. 8.09 Million USD -153.713%
Sotera Health Company 51.98 Million USD 60.502%
bioAffinity Technologies, Inc. 18.48 Thousand USD -110985.263%